Turkish Authorities Investigate Teva for Alleged Patent Manipulation and Misleading Claims

Turkish competition authorities are scrutinizing Teva Pharmaceutical, a global leader in generic drug production, over allegations of engaging in practices designed to unfairly extend its market dominance and undermine rival pharmaceutical products.

Turkish Regulators Launch Probe into Teva's Market Practices

On August 25, 2026, Turkish antitrust regulators initiated an investigation into Teva Pharmaceutical, the world's leading generic drug manufacturer. The probe, announced last Friday on the Rekabet Kurumu website, focuses on whether Teva utilized various tactics to hinder competitors' market entry. These alleged tactics include manipulating the patent system and disseminating misleading information to health care authorities concerning the safety and effectiveness of rival medicines.

While a specific drug was not named in the current investigation, a Teva spokesperson indicated that this inquiry bears similarities to a prior European Commission investigation. That European probe, which concluded two years ago, found Teva guilty of delaying competition for its blockbuster multiple sclerosis drug, Copaxone, resulting in a 3 million fine. Teva is currently appealing that decision before the European Court.

This recent action by Turkey's Competition Board highlights a growing trend of increased scrutiny by Turkish regulators towards global pharmaceutical companies. The authorities are actively working to ensure fair market competition and prevent anticompetitive practices within the pharmaceutical sector.

This investigation underscores the complex landscape of intellectual property rights and market competition within the pharmaceutical industry. It serves as a reminder that regulatory bodies globally are increasingly vigilant in safeguarding fair competition and consumer interests, particularly when it comes to essential medicines. Companies operating in this sector must adhere to ethical and legal standards in their market strategies to avoid significant financial penalties and reputational damage.